Results 71 to 80 of about 7,431 (174)

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime [PDF]

, 2012
Andreas Bauer, L Podola, Antelmo Haule, Lwitiho Sudi, Charlotta Nilsson, Philipp Mann, Marco Missanga, B Kaluwa, Leonard Maboko, Cornelia Lueer, Maria Mwakatima, Said Aboud, M Bakari, Jeffrey R. Currier, ML Robb, Sean B. Joseph, Sheena McCormack, E. F. Lyamuya, Britta Wahrén, Eric Sandström, Gunnel Biberfeld, Michael Höelscher, Arne Kroidl, Christof Geldmacher   +23 more
openalex   +1 more source

Multivalent mpox protein nanoparticle vaccines confer cross-protection against orthopoxvirus infection.

PLoS Pathogens
The outbreak of mpox since 2022 has driven the development of mpox virus (MPXV)-specific, subunit-based, next-generation vaccines, instead of the currently used live-attenuated vaccinia virus (VACV) vaccines.
Lijun Zhang, Chuanyu Liu, Chenxi Yang, Xueqi Xiao, Senyu Xu, Shengfeng Wan, Kun Xu, Yan Li, Lianpan Dai   +8 more
doaj   +1 more source

Modified vaccinia Ankara-Bavarian Nordic vaccine against mpox in children. [PDF]

Lancet Infect Dis, 2023
Turtle L, Subramaniam K.
europepmc   +1 more source

Predicting vaccine effectiveness for mpox

Nature Communications
The Modified Vaccinia Ankara vaccine developed by Bavarian Nordic (MVA-BN) was widely deployed to prevent mpox during the 2022 global outbreak. This vaccine was initially approved for mpox based on its reported immunogenicity (from phase I/II trials) and
Matthew T. Berry, Shanchita R. Khan, Timothy E. Schlub, Adriana Notaras, Mohana Kunasekaran, Andrew E. Grulich, C. Raina MacIntyre, Miles P. Davenport, David S. Khoury   +8 more
doaj   +1 more source

Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells

, 2021
Noam Erez, Linda S. Wyatt, Jeffrey L. Americo, Wei Xiao, Bernard Moss   +4 more
openalex   +2 more sources

Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19

Vaccines
Aging is associated with a decline in immune system functionality. So-called immunosenescence may impair the successful vaccination of elderly people. Thus, improved vaccination strategies also suitable for an aged immune system are required.
Sabrina Clever, Lisa-Marie Schünemann, Federico Armando, Christian Meyer zu Natrup, Tamara Tuchel, Alina Tscherne, Malgorzata Ciurkiewicz, Wolfgang Baumgärtner, Gerd Sutter, Asisa Volz   +9 more
doaj   +1 more source

Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant [PDF]

, 2022
Ning Yang, Aitor Garcia, Cindy Meyer, Thomas Tuschl, Taha Merghoub, Jedd D. Wolchok, Liang Deng   +6 more
openalex   +1 more source

Late‐breaking trials in IBD

United European Gastroenterology Journal, Volume 13, Issue 9, Page 1818-1839, November 2025.
wiley   +1 more source

Can a single dose of Modified Vaccinia Ankara-Bavarian Nordic vaccine protect against mpox? [PDF]

Lancet Infect Dis, 2023
Ogoina D, Strub-Wourgaft N.
europepmc   +1 more source

ISEV2025 Abstract Book

Journal of Extracellular Vesicles, Volume 14, Issue S1, October 2025.
wiley   +1 more source